| |
 |
|
Class Information
Number: 514/8
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai > Glycoprotein (carbohydrate containing)
Description: Subject matter which contains a carbohydrate or derivative thereof attached to the peptide.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6399565 |
Therapeutic use of 20-kilodalton human growth hormone |
Jun. 4, 2002 |
| 6399570 |
Antimicrobial/endotoxin neutralizing polypeptide |
Jun. 4, 2002 |
| 6399577 |
Compositions and methods using myelin-associated glycoprotein (MAG) and inhibitors thereof |
Jun. 4, 2002 |
| 6395268 |
Lymphotactin uses |
May. 28, 2002 |
| 6391589 |
Human chemokine beta-10 mutant polypeptides |
May. 21, 2002 |
| 6391851 |
Hydrochlorides of vancomycin antibiotics and process for producing the same |
May. 21, 2002 |
| 6391857 |
Methods and compositions for endothelial binding |
May. 21, 2002 |
| 6387875 |
Method of use for murine leukaemia inhibitory factor-binding protein (mLBP) |
May. 14, 2002 |
| 6387877 |
Purification method |
May. 14, 2002 |
| 6387884 |
Leukocyte homing modulation |
May. 14, 2002 |
| 6384049 |
Cancer treatment |
May. 7, 2002 |
| 6379678 |
Antigenic preparations |
Apr. 30, 2002 |
| 6379684 |
Cosmetic compositions containing cromolyn compounds for revitalizing the skin |
Apr. 30, 2002 |
| 6380157 |
Method of treatment using papillomavirus L2 protein |
Apr. 30, 2002 |
| 6380165 |
Immunological advanced glycation endproduct crosslink |
Apr. 30, 2002 |
| 6376557 |
Methods for treating alopecia |
Apr. 23, 2002 |
| 6375944 |
Methods and compositions for enhancing the immunostimulatory effect of interleukin-12 |
Apr. 23, 2002 |
| 6375950 |
Methods for inducing T cell unresponsiveness to donor tissue or organ in a recipient with gp39 antagonists |
Apr. 23, 2002 |
| 6372456 |
Polynucleotides encoding chemokine .alpha.-6 |
Apr. 16, 2002 |
| 6372716 |
Formulations for factor IX |
Apr. 16, 2002 |
| 6368619 |
Hydrophobic preparations of hydrophilic species and process for their preparation |
Apr. 9, 2002 |
| 6365570 |
Pharmaceutical and diagnostic use of Serum Amyloid P component |
Apr. 2, 2002 |
| 6361779 |
Transferrin receptor genes |
Mar. 26, 2002 |
| 6362160 |
Immunophilin-binding agents prevent glutamate neurotoxicity associated with vascular stroke and neurodegenerative diseases |
Mar. 26, 2002 |
| 6358504 |
Compounds and compositions for delivering active agents |
Mar. 19, 2002 |
| 6358697 |
Intracellular pharmaceutical targeting |
Mar. 19, 2002 |
| 6358919 |
Polymer compounds comprising glycosphingosine |
Mar. 19, 2002 |
| 6355611 |
Salt form of a conjugate useful in the treatment of prostate cancer |
Mar. 12, 2002 |
| 6355612 |
Protein material for slow digestion and its use |
Mar. 12, 2002 |
| 6352723 |
Brain-derived alkali-soluble immunoregulatory composition |
Mar. 5, 2002 |
| 6350730 |
OB polypeptides and modified forms as modulators of body weight |
Feb. 26, 2002 |
| 6348191 |
Production and use of IL-6 |
Feb. 19, 2002 |
| 6348192 |
Interleukin-2 mutein expressed from mammalian cells |
Feb. 19, 2002 |
| 6346242 |
Compounds and compositions for delivering active agents |
Feb. 12, 2002 |
| 6346513 |
Proteins with factor VIII activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them |
Feb. 12, 2002 |
| 6340696 |
Viral treatment |
Jan. 22, 2002 |
| 6340783 |
Rodent models of human amyloidoses |
Jan. 22, 2002 |
| 6338844 |
Genomic nucleic acids, cDNA and mRNA which code for polypeptides with IL-16 activity, processes for the production thereof and their use |
Jan. 15, 2002 |
| 6338853 |
Anti-cancer vaccine |
Jan. 15, 2002 |
| 6337318 |
Sustained GnRH peptide-release formulation |
Jan. 8, 2002 |
| 6333034 |
Process for inhibiting complement activation via the alternative pathway |
Dec. 25, 2001 |
| 6333304 |
Therapeutic compositions containing glucosamine, collagen and a bioflavanol for repair and maintenance of connective tissue |
Dec. 25, 2001 |
| 6333306 |
Pharmaceutical combination preparations containing erythropoietin and iron preparations |
Dec. 25, 2001 |
| 6333312 |
Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
Dec. 25, 2001 |
| 6326004 |
Antiviral methods using fragments of human rhinovirus receptor (ICAM-1) |
Dec. 4, 2001 |
| 6322779 |
Recombinant human CSF-1 dimer and compositions thereof |
Nov. 27, 2001 |
| 6323176 |
Cyclic peptide antifungal agents |
Nov. 27, 2001 |
| 6323177 |
Interaction of reelin with very low density lipoprotein (VLDL) receptor for screening and therapies |
Nov. 27, 2001 |
| 6323178 |
Beta-lipotropin methods |
Nov. 27, 2001 |
| 6319493 |
Treatment of neoplastic disease with interleukin-10 |
Nov. 20, 2001 |
|
|
|
